New Symbols – Single Stock CFDs (Broker Liquidity)

Company News | +61 2 9083 1333 | 2020.08.07

Keep up to date with Invast Global’s expanding Single Stock CFD & ETF offering, here is a snapshot of our latest additions. To ensure that you are subscribed to our full universe of symbols, please download our latest configuration files from the Technical Guide in Section 6 of the Client Portal.

CLIENT PORTAL                 FIND OUT MORE

 

New Single Stock CFDs

These new symbols were added to the Invast Global DMA Universe from 03/08/20 – 11/08/20
 

Core Symbol Base Currency Exchange
Evergy USD NYS
Coca-ColaEuropeanPartnersNYS EUR AMS
GWPharmaceuticalsADR USD NAS
TUIG EUR ETR
VolkswagenORD EUR ETR
DistribuidoraInternacional EUR MAD

 

Download List of Single Stock CFDs


Evergy

 

Market Cap: 12.414 Billion
YTD Return:
: -14.54%
Avg. Volume: 2.683 Million

Evergy engages in the generation,  transmission, distribution, and sale of electricity in Kansas and Missouri. It generates electricity through coal, nuclear, natural gas and oil, uranium, wind, hydroelectric, landfill gas, and solar energy sources, as well as other renewable sources.

 

Coca-Cola European Partners PLC

Market Cap: 15.311 Billion
YTD Return:
: -20.18%
Avg. Volume: 70,928

Coca-Cola European Partners sells a range of non-alcoholic ready-to-drink beverages. As of March 16, 2020, it served approximately 300 million consumers across Western Europe, including Andorra, Belgium, continental France, Germany, Great Britain, Iceland, Luxembourg, Monaco, the Netherlands, Norway, Portugal, Spain, and Sweden.

 

GW Pharmaceuticals

Market Cap: 4.323 Billion
YTD Return: 26.34%
Avg. Volume: 340,296

GW Pharmaceuticals is a British Pharmaceutical company which has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW successfully developed the world’s first prescription medicine derived from the cannabis plant called Sativex and has developed an oral formulation of purified cannabidiol (CBD), initially approved as EPIDIOLEX in the US for the treatment of seizures.

 

Disclaimer: This material is provided to you by Invast Global is solely for informational purposes, is intended for your use only and does not constitute an offer or commitment, a solicitation of an offer or comment, or any advice or recommendation, to enter into or conclude any transaction. Please refer to our PDS available on our website for further information.

 

Return to Insights